Drug Price Trends for MUCUS RELIEF PE TABLET

Average Pharmacy Cost for MUCUS RELIEF PE TABLET

These are average pharmacy acquisition costs (net of discounts) from a US national survey

Drug Name	NDC	Price/Unit ($)	Unit	Date
MUCUS RELIEF PE TABLET	70000-0141-01	0.08290	EACH	2024-12-18
MUCUS RELIEF PE TABLET	70000-0141-01	0.08407	EACH	2024-11-20
MUCUS RELIEF PE TABLET	70000-0141-01	0.08472	EACH	2024-10-23
MUCUS RELIEF PE TABLET	70000-0141-01	0.08165	EACH	2024-09-18
MUCUS RELIEF PE TABLET	70000-0141-01	0.07986	EACH	2024-08-21

MUCUS RELIEF PE TABLET Market Analysis and Financial Projection

Market Analysis and Price Projections for MUCUS RELIEF PE Tablet

Market Overview

The market for over-the-counter (OTC) expectorant drugs, including MUCUS RELIEF PE, is experiencing significant growth driven by consumer self-medication for common colds, coughs, and respiratory allergies.

Global Market Share and Growth

The OTC segment is expected to dominate the market, holding a 75% global market share by 2024. The expectorant drugs market, particularly the secretion enhancers category, is projected to grow rapidly, with a Compound Annual Growth Rate (CAGR) of 6.8% in the United States and 6.7% in the United Kingdom through 2034[3].

Product Details and Efficacy

MUCUS RELIEF PE tablets combine two active ingredients: guaifenesin and phenylephrine.

• Guaifenesin: Acts as an expectorant, helping to loosen and thin mucus in the airways, making it easier to cough up and expel phlegm[2][5].
• Phenylephrine: Serves as a nasal decongestant, reducing swelling and congestion in the nasal passages by constricting blood vessels[2][5].

This combination provides comprehensive relief from chest and nasal congestion, sinus pressure, and related symptoms.

Target Market and Consumer Preferences

The primary consumers of MUCUS RELIEF PE are individuals suffering from respiratory congestion due to the common cold, flu, or seasonal allergies. The market is driven by consumer preferences for self-medication and the convenience of OTC products.

Demographic Influence

The demand for expectorant drugs is influenced by population demographics, with a growing number of innovative products for children expected to increase demand for OTC products. In regions like the United States, Germany, India, and China, the market is anticipated to expand significantly due to increasing consumer awareness and the need for quick relief from respiratory symptoms[3].

Price Projections and Affordability

Current Pricing

The cost for MUCUS RELIEF PE tablets is relatively affordable, with a supply of 60 tablets costing around $11, depending on the pharmacy. Generic versions of guaifenesin are also available, starting from $9.90 for 20 tablets[4].

Discounts and Patient Assistance

Consumers can benefit from discount cards and patient assistance programs, such as the Drugs.com Discount Card, which can save up to 80% on prescription and OTC medications, including MUCUS RELIEF PE[4].

Regulatory Considerations

FDA Proposals

It is important to note that the U.S. Food and Drug Administration (FDA) has proposed an order to remove oral phenylephrine from the OTC monograph, although this proposal is not related to safety concerns. This could potentially impact the formulation and availability of MUCUS RELIEF PE in the future[1].

Market Trends and Future Outlook

Innovation and R&D

The market is expected to see continued innovation, with new formulations and products being developed to enhance secretion and provide better relief from respiratory disorders. This ongoing research and development will likely drive demand and growth in the coming years[3].

Seasonal Demand

Demand for expectorant drugs like MUCUS RELIEF PE tends to fluctuate with the cold and flu season, indicating a seasonal pattern in consumer demand. As respiratory infections increase during these periods, the demand for medications to treat cough and congestion also rises[3].

Key Takeaways

• Market Dominance: OTC expectorant drugs, including MUCUS RELIEF PE, are expected to dominate the market with a 75% global share.
• Growth Projections: The market is projected to grow at a CAGR of 6.8% in the United States and 6.7% in the United Kingdom through 2034.
• Affordability: MUCUS RELIEF PE is priced affordably, with options for discounts and patient assistance programs.
• Regulatory Considerations: The FDA's proposed order to remove oral phenylephrine from the OTC monograph may impact future formulations.
• Innovation: Ongoing R&D is expected to drive market growth with new and improved formulations.

Frequently Asked Questions (FAQs)

1. What are the active ingredients in MUCUS RELIEF PE?

• The active ingredients are guaifenesin (expectorant) and phenylephrine (nasal decongestant)[2][5].

2. How does MUCUS RELIEF PE work?

• It helps loosen and thin mucus, making it easier to cough up, and reduces nasal congestion by constricting blood vessels in the nasal passages[2][5].

3. What is the typical dosage for MUCUS RELIEF PE?

• Adults and children 12 years and older should take 1 tablet every 4 hours as needed, not exceeding 6 tablets in 24 hours[2].

4. Is MUCUS RELIEF PE available in generic form?

• Yes, generic versions of guaifenesin are available, starting from $9.90 for 20 tablets[4].

5. Are there any discounts or patient assistance programs available for MUCUS RELIEF PE?

• Yes, consumers can use discount cards like the Drugs.com Discount Card to save up to 80% on the cost of the medication[4].

Cited Sources

1. SUDAFED PE® Head Congestion & Mucus Relief Medicine - Sudafed
2. Rugby Chest Congestion Relief PE - 60 Tablets (Mucinex Sinus) - Xeteor
3. Global Expectorant Drugs Market Growth Projection 2024-2034 - Future Market Insights
4. Mucus Relief Prices, Coupons, Copay Cards & Patient Assistance - Drugs.com
5. MUCUS RELIEF PE- guaifenesin, phenylephrine hcl tablet, film coated - DailyMed